当前位置:首页  郭 行  发表论文


1. Yan, F., Huang, C., Wang, X., Tan, J., Cheng, S., Wan, M., Wang, Z., Wang, S., Luo, S., Li, A., Guo, X., Feng, M., Liu, X., Zhu, Y., Zhou, Y. Threonine ADP-Ribosylation of Ubiquitin by a Bacterial Effector Family Blocks Host Ubiquitination. Mol Cell 2020 pii: S1097-2765(20)30164-7.

2. Liu, X., Xiao, W., Zhang, Y., Wiley, S.E., Zuo, T., Zheng, Y., Chen, N., Chen, L., Wang, X, Zheng, Y., Huang, L., Lin, S., Murphy, A.N., Dixon, J.E., Xu, P. and Guo, X.* Reversible phosphorylation of Rpn1 regulates 26S proteasome assembly and function. Proc Natl Acad Sci U S A. 2020, 117:328-336 *corresponding author

3. Fan, K., Wang, F., Li, Y., Chen, L., Gao, Z., Zhang, Y., Duan, J., Huang, T., Zhong, J., Liu, RB., Mao, X., Fan, H., Guo, X.* and Jin, J.* CRL4DCAF2 is required for mature T-cell expansion via Aurora B-regulated proteasome activity. J Autoimmun. 2019, 96:74-85 *corresponding author

4. Banerjee, S., Ji, C., Mayfield, J.E., Goel, A., Xiao, J., Dixon, J.E.* and Guo, X.* Ancient drug curcumin impedes 26S proteasome activity by direct inhibition of dual-specificity tyrosine-regulated kinase 2. Proc Natl Acad Sci U S A. 2018, 115:8155-8160 *corresponding author

5. Ma, XJ., Chen, X., Jin, Y., Ge, WY., Wang, WY., Kong, LH., Ji, JF., Guo, X., Huang, J., Feng, XH,, Fu, JF., Zhu, SY. Small molecules promote CRISPR-Cpf1-mediated genome editing in human pluripotent stem cells. Nature Communications 2018, 9:1303.

6. Zhang, H., Zhu, Q., Cui, J., Wang, Y., Chen, M. J., Guo, X., Tagliabracci, V. S., Dixon, J. E. & Xiao, J. Structure and evolution of the Fam20 kinases. Nature Communications 2018, 9:1218.

7. Chen, Y., Zhang Y. and Guo, X.* Proteasome dysregulation in human cancer: Implications for clinical therapies. Cancer and Metastasis Reviews 2017, 36:703-716. *corresponding author

8. Wang, X., Cimermancic, P., Yu, C., Schweitzer, A., Chopra, N., Engel, J.L., Greenberg, C., Huszagh, A.S., Beck, F., Sakata, E., Yang, Y., Novitsky, E.J., Leitner, A., Nanni, P., Kahraman, A., Guo, X., Dixon, J.E., Rychnovsky, S.D., Aebersold, R., Baumeister, W., Sali, A., and Huang, L. Molecular Details Underlying Dynamic Structures and Regulation of the Human 26S Proteasome. Mol Cell Proteomics 2017, 16:840-854.

9. Guo, X.*, Huang, X., and Chen, M.J. Reversible phosphorylation of the 26S proteasome. Protein & Cell 2017, 8:255-272. *corresponding author

10. Guo, X.* and Dixon, J.E.* The 26S proteasome: a cell cycle regulator regulated by cell cycle, Cell Cycle 2016, 15:875-876. *co-corresponding author

11. Guo, X.*, Wang, X., Wang Z., Banerjee, S., Yang J., Huang L., and Dixon, J.E.* Site-specific Proteasome Phosphorylation Controls Cell Proliferation and Tumorigenesis. Nature Cell Biology 2016, 18:202–212. *co-corresponding author

12. He, Y., Guo, X., Yu, Z.-H., Wu, L., Gunawan, A.M., Zhang, Y., Dixon, J.E., and Zhang, Z.-Y. A potent and selective inhibitor for the UBLCP1 proteasome phosphatase. Bioorganic & Medicinal Chemistry 2015, 23:2798–2809.

13. Wang, Z., Hou, Y#., Guo, X.#, van der Voet, M., Boxem, M., Dixon, J.E., Chisholm, A.D. and Jin, Y. The EBAX-type Cullin-RING E3 Ligase and Hsp90 Guard the Protein Quality of the SAX-3/Robo Receptor in Developing Neurons. Neuron 2013, 79:903–916. #Equal contribution

14. Guo, X.*, and Wang, X.-F*. A P(E)RM(I)T for BMP Signaling. Molecular Cell 2013, 51:1-2.*co-corresponding author

15. Guo, X.*, and Wang, X.-F*. A Mediator Lost in the War on Cancer. Cell 2012, 151:927-929.*co-corresponding author

16. Guo, X.*, and Wang X.-F*. New secrets behind bone metastasis. Cell Research 2012, 22:1309-1311. *co-corresponding author

17. Guo, X., Engel, J.L., Xiao, J., Tagliabracci, V.S., Wang, X., Huang, L., and Dixon, J.E. UBLCP1 is a 26S proteasome phosphatase that regulates nuclear proteasome activity. Proceedings of the National Academy of Sciences 2011, 108:18649-18654.

18. Guo, X., Wang X.-F. Signaling cross-talk between TGF-β/BMP and other pathways. Cell Research 2009, 19:71-88.

19. Guo, X.#, Waddell, D. S.#, Wang, W., Wang, Z., Liberati, N. T., Yong, S., Liu X. and Wang X.-F. Ligand-Dependent Ubiquitination of Smad3 Is Regulated by Casein Kinase 1 gamma 2 (CKIγ2), An Inhibitor of TGF-β Signaling. Oncogene  2008, 27:7235–7247. #Equal contribution

20. Lee Y.-S., Lim K.-H., Guo, X., Kawaguchi Y., Gao Y., Barrientos T., Ordentlich P., Wang X.-F., Counter C. and Yao T.-P. The cytoplasmic deacetylase HDAC6 is required for efficient oncogenic tumorigenesis. Cancer Research 2008, 68:7561-7569.

21. Guo, X., Ramirez, A., Waddell, D. S., Li, Z., Liu, X., and Wang, X.-F. Axin and GSK3-β control Smad3 protein stability and modulate TGF-β signaling. Genes & Development 2008, 22:106-120.

22. Hjelmeland, A. B., Schilling, S. H., Guo, X., Quarles, D., and Wang, X.-F. Loss of Smad3-Mediated Negative Regulation of Runx2 Activity Leads to an Alteration in Cell Fate Determination. Molecular and Cellular Biology 2005, 25:9460-9468.

23. Waddell, D. S., Liberati, N. T., Guo, X., Frederick, J. P., and Wang, X.-F. Casein Kinase Iε Plays a Functional Role in the Transforming Growth Factor-β Signaling Pathway. Journal of Biological Chemistry 2004, 279:29236-29246.

24. Shao, R., and Guo, X. Human microvascular endothelial cells immortalized with human telomerase catalytic protein: a model for the study of in vitro angiogenesis. Biochemical and Biophysical Research Communications 2004, 321:788-794.

25. Zhou, C., Wen, Z.-X., Wang, Z.-P., Guo, X., Shi, D.-M., Zuo, H.-C., and Xie, Z.-P. Green fluorescent protein-labeled mapping of neural stem cells migrating towards damaged areas in the adult central nervous system. Cell Biology International 2003, 27:943-945.